IL-13 polymorphisms contribute to the risk of asthma: A meta-analysis

Clinical Biochemistry

Volumn 45, Issue 4-5, 2012, Pages 285-288

  Cui, Lin ^a   Jia, Jing ^b   Ma, Chun Fen ^c   Li, Su Yun ^a   Wang, You Ping ^a   Guo, Xiao Min ^d   Li, Qiang ^a   Yu, Hai Bin ^a   Liu, Wei Hong ^a   Gao, Lin Bo ^e,f  

^a THE FIRST AFFILIATED HOSPITAL OF HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^d HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e SICHUAN UNIVERSITY   (China)

^f BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Asthma; IL 13; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 13;

ARTICLE; ASTHMA; CAUCASIAN; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADULT; AGE OF ONSET; AMINO ACID SUBSTITUTION; ASTHMA; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; HUMANS; INTERLEUKIN-13; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84862799539     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.12.012     Document Type: Article

References (36)

1. Los H., Koppelman G.H. Postma DS. The importance of genetic influences in asthma. Eur Respir J 1999, 14:1210-1227.
2. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
3. de Waal Malefyt R., Abrams J.S., Zurawski S.M., Lecron J.C., Mohan-Peterson S., Sanjanwala B., et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995, 7:1405-1416.
4. Jung T., Wijdenes J., Neumann C., de Vries J.E., Yssel H. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur J Immunol 1996, 26:571-577.
5. Van der Pouw Kraan T.C., Van der Zee J.S., Boeije L.C., De Groot E.R., Stapel S.O., Aarden L.A. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol 1998, 111:129-135.
6. Liu X., Nickel R., Beyer K., Wahn U., Ehrlich E., Freidhoff L.R., et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000, 106:167-170.
7. Heinzmann A., Mao X.Q., Akaiwa M., Kreomer R.T., Gao P.S., Ohshima K., et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000, 9:549-559.
8. Chen W., Ericksen M.B., Levin L.S., Khurana Hershey G.K. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J Allergy Clin Immunol 2004, 114:553-560.
9. Vladich F.D., Brazille S.M., Stern D., Peck M.L., Ghittoni R., Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005, 115:747-754.
10. Graves P.E., Kabesch M., Halonen M., Holberg C.J., Baldini M., Fritzsch C., et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000, 105:506-513.
11. Vercelli D. Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol 2002, 2:389-393.
12. Leung T.F., Tang N.L., Chan I.H., Li A.M., Ha G., Lam C.W. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001, 31:1515-1521.
13. Howard T.D., Whittaker P.A., Zaiman A.L., Koppelman G.H., Xu J., Hanley M.T., et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001, 25:377-384.
14. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
15. Chan I.H., Leung T.F., Tang N.L., Li C.Y., Sung Y.M., Wong G.W., et al. Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children. J Allergy Clin Immunol 2006, 117:127-133.
16. Kim H.B., Lee Y.C., Lee S.Y., Jung J., Jin H.S., Kim J.H., et al. Gene-gene interaction between IL-13 and IL-13Ralpha1 is associated with total IgE in Korean children with atopic asthma. J Hum Genet 2006, 51:1055-1062.
17. Kang M.J., Lee S.Y., Kim H.B., Yu J., Kim B.J., Choi W.A., et al. Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction. Pharmacogenet Genomics 2008, 18:551-558.
18. Larocca N.E., Moreno D., Toro F., Garmendia J.V., De Sanctis J.B. IL-4, intron 3 variable number tandem repeats analysis (VNTR), and IL-13-1055 gene polymorphism in patients with asthma and COPD in Venezuela. J Allergy Clin Immunol 2008, 121:S77.
19. Thakkinstian A., McEvoy M., Minelli C., Gibson P., Hancox B., Duffy D., et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
20. Larocca N., Moreno D., Garmendia J., Toro F., De Sanctis J., et al. IL-4, intron 3 variable number tandem repeats analysis (VNTR), and IL-13-1055 SNP gene polymorphism in patients with asthma and chronic obstructive pulmonary disease in Venezuela. Allergy Eur J Allergy Clin Immunol 2010, 65:338.
21. Moissidis I., Chinoy B., Yanamandra K., Napper D., Thurmon T., Bocchini T., et al. Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genet Med 2005, 7:406-410.
22. Yang G., Li L., Volk A., Emmell E., Petley T., Giles-Komar J., et al. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice. J Pharmacol Exp Ther 2005, 313:8-15.
23. Yang G., Volk A., Petley T., Emmell E., Giles-Komar J., Shang X., et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004, 28:224-232.
24. Black S., Teixeira A.S., Loh A.X., Vinall L., Holloway J.W., Hardy R., et al. Contribution of functional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy 2009, 64:1172-1178.
25. Bottema R.W., Nolte I.M., Howard T.D., Koppelman G.H., Dubois A.E., de Meer G., et al. Interleukin 13 and interleukin 4 receptor-alpha polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol 2010, 153:259-267.
26. Chan I.H., Tang N.L., Leung T.F., Huang W., Lam Y.Y., Li C.Y., et al. Study of gene-gene interactions for endophenotypic quantitative traits in Chinese asthmatic children. Allergy 2008, 63:1031-1039.
27. Dmitrieva-Zdorova E.V., Voronko O.E., Aksenova M.G., Bodoev N.V. Association of interleukin-13 gene polymorphisms with atopic bronchial asthma. Russ J Genet 2010, 46:99-104.
28. Donfack J., Schneider D.H., Tan Z., Kurz T., Dubchak I., Frazer K.A., et al. Variation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy. Respir Res 2005, 6:145.
29. Kim H.B., Kang M.J., Lee S.Y., Jin H.S., Kim J.H., Kim B.S., et al. Combined effect of tumour necrosis factor-alpha and interleukin-13 polymorphisms on bronchial hyperresponsiveness in Korean children with asthma. Clin Exp Allergy 2008, 38:774-780.
30. Llanes E., Quiralte J., Lopez E., Sastre B., Chacartegui M., del Pozo V., et al. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol 2009, 148:228-238.
31. Lopez K.I., Martinez S.E., Moguel M.C., Romero L.T., Figueroa C.S., Pacheco G.V., et al. Genetic diversity of the IL-4, IL-4 receptor and IL-13 loci in mestizos in the general population and in patients with asthma from three subpopulations in Mexico. Int J Immunogenet 2007, 34:27-33.
32. Palikhe N.S., Kim S.H., Cho B.Y., Choi G.S., Kim J.H., Ye Y.M., et al. IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma. Allergy Asthma Immunol Res 2010, 2:134-140.
33. van der Pouw Kraan T.C., van Veen A., Boeije L.C., van Tuyl S.A., de Groot E.R., Stapel S.O., et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999, 1:61-65.
34. Wang J., Liou Y., Wu Y., Hsiao Y., Wu L. An association study of 13 SNPs from seven candidate genes with pediatric asthma and a preliminary study for genetic testing by multiple variants in Taiwanese population. J Clin Immunol 2009, 29:205-209.
35. Wu X., Li Y., Chen Q., Chen F., Cai P., Wang L., et al. Association and gene-gene interactions of eight common single-nucleotide polymorphisms with pediatric asthma in middle china. J Asthma 2010, 47:238-244.
36. Denham S., Koppelman G.H., Blakey J., Wjst M., Ferreira M.A., Hall I.P., et al. Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir Res 2008, 9:38.